Publish Date: 
Friday, November 30, 2018 - 12:45

Metro South Health 2019 Research Support Scheme

The following winners are TRI members and regularly work out of TRI.

EARLY CAREER RESEARCHER – PROJECT GRANTS | up to $75,000 over 2 years

Translation of the Mediterranean Diet into practice for management of chronic disease patients
Research team: Dr Hannah Mayr, Nutrition & Dietetics PAH with Dr Ingrid Hickman, A/Prof Graeme Macdonald, A/Prof Katrina Campbell, Dr Michelle Palmer, A/Prof Anthony Russell, A/Prof Sudhir Wahi

Defining then novel effects of mineralocorticoid receptor antagonism on metabolism—a randomised controlled trial
Research team: Dr Moe Thuzar, Endocrinology PAH with Prof Michael Stowasser, A/Prof Anthony Russell, Dr Ingrid Hickman, Dr Weikiat Phillip Law, Prof Ken Ho

INNOVATION (seed) – SMALL GRANTS | up to $25,000 over 2 years

Studying antiviral responses within the nasal epithelium as a window into disordered mucosal host defence in people with COPD
Research team: Prof John Upham, Respiratory & Sleep Medicine PAH with Prof Kirsten Spann, Dr Natale Snape

NOVICE RESEARCHER – SMALL GRANTS | up to $25K over 2 years

Gut reaction—the gastrointestinal microbiota and kidney transplantation
Research team: Dr Samuel Chan, Nephrology PAH with Prof David Johnson, Prof Mark Morrison, A/Prof Katrina Campbell, A/Prof Scott Campbell, Dr Ross Francis, Ms Elaine Pascoe

PROJECT GRANTS | up to $100,000 over 2 years

When drugs don’t work: tailored behavioural intervention for alcoholic hepatitis
Research team: Prof Jason Connor, Alcohol & Drug Unit PAH with Dr Paul Clark, A/Prof Gerald Feeney, Dr Matthew Gullo, Prof Gerald Holtmann,
A/Prof Graeme Macdonald

Modulation of the gastrointestinal microbiome with probiotics and subsequent methane production as a novel approach to treat constipation: a proof of principle study
Research team: Prof Gerald Holtmann, Gastroenterology and Hepatology PAH with Prof Mark Morrison, Dr Ayesha Shah, Dr Anh Do, Dr Natasha Koloski,
Dr Marcus Gray

The Hi-FIVE (Hi Fibre & Influenza Vaccine Effectiveness) Project
Research team: Prof John Upham, Respiratory & Sleep Medicine PAH with Dr Heidi Staudacher, Dr Natale Snape, Prof Lisa Wood

ApPhase Ib, single centre, open label study of a therapeutic Human Papillomavirus (HPV) DNA vaccine co-administered with anti-PD-L1 immunotherapy, durvalumab (MEDI4736), for recurrent and/or metastatic HPV-related head and neck cancer
Research Team: Prof Sandro V Porceddu, Radiation Oncology PAH with Prof Ian Frazer, Dr Rahul Ladwa, Dr Ben Panizza

PROGRAM GRANTS | up to $250,000 over 3 years

Towards collaborative management of people with non-alcoholic fatty liver disease (NAFLD): exploring a pragmatic approach to risk stratification pathways for NAFLD across the care continuum
Research team: Prof Elizabeth Powell, Hepatology PAH with A/Prof Steven McPhail, Dr Laurence Britton, Dr Caroline McIvor, Ms Kelly Hayward, Dr Sue Williams,
Prof William Rosenberg 

Tumour neo-antigen-specific immune responses in oesophageal cancer long-term survivors: proof-of-concept for improved personalised therapeutic strategies
Research team: Dr Andrew Barbour, Surgery PAH with Prof Riccardo Dolcetti, A/Prof Lutz Krause, Dr Lauren Aoude

Download [PDF 460kb] the full list of Metro South Health 2019 Research Support Scheme recipients.

The Metro South Health Research Support Scheme (RSS) is administered by the Centres for Health Research and aims to award excellence in research that translates research discoveries into health and medical outcomes. Find out more.